PD and the Future: The Role of PD in the Overall Management of ESRD

Publisher： Karger

E-ISSN： 1421-9735|21|1|24-28

ISSN： 0253-5068

Source： Blood Purification, Vol.21, Iss.1, 2003-01, pp. : 24-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The ADEMEX Study and PD Adequacy

By  

Blood Purification, Vol. 21, Iss. 1, 2003-01 ,pp. : 37-41

Karger

Access to resources Recommend Favorite

Role of Inflammation and Its Treatment in ESRD Patients

By  

Blood Purification, Vol. 20, Iss. 1, 2002-01 ,pp. : 70-80

Karger

Access to resources Recommend Favorite

Routine Monitoring of Sodium and Phosphorus Removal in Peritoneal Dialysis (PD) Patients Treated with Continuous Ambulatory PD (CAPD), Automated PD (APD) or Combined CAPD+APD

By  

Kidney and Blood Pressure Research, Vol. 42, Iss. 2, 2017-05 ,pp. : 257-266

Karger

Access to resources Recommend Favorite

Delivered Dialysis Dose with PD Plus Therapy

By  

American Journal of Nephrology, Vol. 18, Iss. 6, 1998-12 ,pp. : 520-524

Karger

Access to resources Recommend Favorite

Preservation of Renal Function: HDF versus PD

By  

Blood Purification, Vol. 22, Iss. 2, 2005-01 ,pp. : 34-35

Karger

Access to resources Recommend Favorite